362 related articles for article (PubMed ID: 21426110)
1. The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development.
Yu XQ; Wilson AG
Future Med Chem; 2010 Jun; 2(6):923-8. PubMed ID: 21426110
[No Abstract] [Full Text] [Related]
2. Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.
Peters SA; Ungell AL; Dolgos H
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):509-18. PubMed ID: 19562647
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers and biomeasures: key enablers for pharmacokinetic-pharmacodynamic modeling in drug discovery and development.
Agoram BM; van der Graaf PH
Bioanalysis; 2012 Jun; 4(10):1143-5. PubMed ID: 22651555
[No Abstract] [Full Text] [Related]
4. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
Gabrielsson J; Green AR
J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
[TBL] [Abstract][Full Text] [Related]
5. Physiologically based pharmacokinetics (PBPK).
Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic modeling in vivo.
Holford NH; Sheiner LB
Crit Rev Bioeng; 1981; 5(4):273-322. PubMed ID: 7023829
[TBL] [Abstract][Full Text] [Related]
7. What happened to the modeling and simulation revolution?
Bonate PL
Clin Pharmacol Ther; 2014 Oct; 96(4):416-7. PubMed ID: 25236664
[No Abstract] [Full Text] [Related]
8. Impact of modeling and simulation: myth or fact?
Allerheiligen SR
Clin Pharmacol Ther; 2014 Oct; 96(4):413-5. PubMed ID: 25236663
[No Abstract] [Full Text] [Related]
9. Application of PBPK modelling in drug discovery and development at Pfizer.
Jones HM; Dickins M; Youdim K; Gosset JR; Attkins NJ; Hay TL; Gurrell IK; Logan YR; Bungay PJ; Jones BC; Gardner IB
Xenobiotica; 2012 Jan; 42(1):94-106. PubMed ID: 22035569
[TBL] [Abstract][Full Text] [Related]
10. Impact of physiologically based pharmacokinetic modeling and simulation in drug development.
Shardlow CE; Generaux GT; Patel AH; Tai G; Tran T; Bloomer JC
Drug Metab Dispos; 2013 Dec; 41(12):1994-2003. PubMed ID: 24009310
[TBL] [Abstract][Full Text] [Related]
11. Predicting Human Pharmacokinetics: Physiologically Based Pharmacokinetic Modeling and In Silico ADME Prediction in Early Drug Discovery.
Shi J; Zha W
Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):135-137. PubMed ID: 30136219
[No Abstract] [Full Text] [Related]
12. Integration of in silico and in vitro platforms for pharmacokinetic-pharmacodynamic modeling.
Sung JH; Esch MB; Shuler ML
Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1063-81. PubMed ID: 20540627
[TBL] [Abstract][Full Text] [Related]
13. Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.
Agoram BM; Demin O
Drug Discov Today; 2011 Dec; 16(23-24):1031-6. PubMed ID: 22020181
[TBL] [Abstract][Full Text] [Related]
14. On nonoscillation and monotonicity of solutions of nonnegative and compartmental dynamical systems.
Chellaboina V; Haddad WM; Bailey JM; Ramakrishnan J
IEEE Trans Biomed Eng; 2004 Mar; 51(3):408-14. PubMed ID: 15000372
[TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic (PBPK) modeling: it is here to stay!
Rostami-Hodjegan A; Tamai I; Pang KS
Biopharm Drug Dispos; 2012 Mar; 33(2):47-50. PubMed ID: 22351594
[No Abstract] [Full Text] [Related]
16. Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates.
Palucki M; Higgins JD; Kwong E; Templeton AC
J Med Chem; 2010 Aug; 53(16):5897-905. PubMed ID: 20527889
[No Abstract] [Full Text] [Related]
17. The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal lives.
Bueters T; Ploeger BA; Visser SA
Drug Discov Today; 2013 Sep; 18(17-18):853-62. PubMed ID: 23665277
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in physicochemical and ADMET profiling in drug discovery.
Wang J; Skolnik S
Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
[TBL] [Abstract][Full Text] [Related]
19. Physiologically based pharmacokinetic (PBPK) modeling in children.
Barrett JS; Della Casa Alberighi O; Läer S; Meibohm B
Clin Pharmacol Ther; 2012 Jul; 92(1):40-9. PubMed ID: 22669290
[TBL] [Abstract][Full Text] [Related]
20. On setting the first dose in man: quantitating biotherapeutic drug-target binding through pharmacokinetic and pharmacodynamic models.
Lowe PJ; Tannenbaum S; Wu K; Lloyd P; Sims J
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):195-209. PubMed ID: 20050847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
